- Service Name
EpiSwitch® Platform
- Industry
Biotechnology, healthcare, precision medicine, cancer diagnostics
- Main Value Proposition
The EpiSwitch® Platform empowers individuals to make informed health decisions while addressing the rising costs of healthcare through accurate and effective testing.
- Description
The EpiSwitch® Platform offers advanced clinical smart tests that utilize 3D gene regulation technology to aid in precision medicine. It provides accurate assessments for prostate cancer risk and therapeutic success of cancer treatments.
- Key Features
94% accuracy in detecting prostate cancer risk from blood; Guidance on therapeutic success for immune checkpoint inhibitors; Reproducible translation of 3D genome regulation for clinical application; Reduction of unnecessary biopsies and treatments
- Use Cases
The EpiSwitch® Platform is most valuable for prostate cancer screening, assessing therapeutic success of cancer treatments, and guiding clinical decisions in precision medicine.
- Competitive advantages
High accuracy in cancer risk assessment and treatment guidance; Reduction in unnecessary medical procedures; Innovative use of 3D gene regulation technology
- Strengths
The service stands out for its high accuracy, innovative technology, and ability to significantly improve patient outcomes in cancer screening and treatment.
- Positioning
The service positions itself as a leader in precision medicine, focusing on innovative solutions that enhance cancer diagnosis and treatment.
- Audience
Target users include oncologists, healthcare providers, and patients facing cancer treatment decisions, particularly those at risk for prostate cancer.
- Brand Positioning
Oxford BioDynamics is positioned as a cutting-edge biotechnology company dedicated to advancing healthcare through biomarker research and development.
- CTA
Learn More about EpiSwitch CiRT
- Differentiation
The EpiSwitch® Platform is unique in its ability to leverage 3D genomics for precision medicine, providing insights that are not available through traditional testing methods.
- Tagline
Commercializing EpiSwitch® 3D gene regulation for precision medicine
- Tags
precision medicine
cancer diagnostics
biomarker research
3D genomics
- Tone of Voice
Innovative, authoritative, supportive
- Founded
2007-01-01
- Founders
Aroul Ramadass